Results 31 to 40 of about 8,001,103 (290)

Pharmacists’ Experiences on Adverse Drug Reactions in Saudi Arabia: A Cross-Sectional Study

Pharmacy
Background and objectives: As part of Vision 2030, Saudi Arabia aims to strengthen its healthcare system by enhancing efficiency, reducing medical errors, and ensuring drug safety.
Dalal Salem Bakheit Aldossari, Naeema Taha Alshalaan, Khuloud Salem Alshammari, Fatima Ahmed Lubbad, Mudhi Ratyan Alanazi, Neamah Ahmed Lubbad, Nada Suliman Fahad Alessa, Sheraz Ali   +7 more
doaj   +1 more source

Comparing cost-sharing practices for pharmaceuticals and health care services among four central European countries [PDF]

, 2012
The paper reviews the existing cost-sharing practices in four Central European countries namely the Czech Republic, Hungary, Poland and Slovakia focusing on patient co-payments for pharmaceuticals and services covered by the social health insurance.
Boncz, I., Baji, Petra, Jenei, G., Baji, P., Jenei, György, Gulácsi, László, Gulácsi, L., Boncz, Imre, László Gulácsi, György Jenei, Petra Baji, Imre Boncz   +11 more
core   +1 more source

Cutaneous actinomycosis and long-term management through using oral and topical antibiotics: A case report

Clinics and Practice, 2018
Actinomycosis is a subacute or chronic suppurative bacterial infection which caused because of filamentous gram-positive, anaerobic to microaerophilic nonacid fast bacilli primarily of the genus Actinomyces that normally colonize the mouth, colon, and ...
Ali Hassan Najmi, Ibrahim Hassan Najmi, Mosa Mohmmed Hassan Tawhari, Khadija Hafed Sawadi, Khaled Ahamed Hassan Khbrani, Fawaz Hadi Tawhari, Mohammed Abdu Tawhari, Majed Hassan Mathkur, Khalid Mohammed Al-attas   +8 more
doaj   +1 more source

A Method of Evaluating Pharmaceutical Care Services

Iryo Yakugaku (Japanese Journal of Pharmaceutical Health Care and Sciences), 2005
Since 1988, hospital pharmacists in Japan have been developing clinical pharmacy services for inpatients whose aims are to promote proper drug use and effective risk management. Health insurance reimbursement fees for inpatient pharmaceutical care services have increased tremendously since 1988 and this indicates that pharmaceutical care services are ...
Nakata, Doolin Eiko, Orii, Takao, Sakakibara, Kenitirou, Yasumizu, Takehiko   +3 more
openaire   +2 more sources

Pharmaceutical care practice : drug-related problems and opportunities for new services [PDF]

, 2010
Within the last decades, the role of the pharmacist and of pharmacy practice have moved from that of drug manufacturing and technical dispensing to a more cognitive role with patient orientation.
Eichenberger, Patrick Marc
core   +1 more source

EVOLUTION AND ADVANCEMENTS IN THE DEVELOPMENT OF PHARMACEUTICAL CARE SERVICES

EPH - International Journal of Medical and Health Science, 2022
The evolution of pharmaceutical care services has undergone a significant transformation, shifting from a product-focused approach to a patient-centered model. This article explores the historical development, patient-centered approach, Medication Therapy Management (MTM) programs, collaborative care, technological integration, challenges, and future ...
AL Mogrin, Maha Mohammed, Al Khleb, Aseel Abdulziz, Al Shehri, Bshayer Mohammed, Al Shreeaf, Khalid Abdulrahman, Al Busaysi, Khaled Farhan, Al Rashidi, Ahmed Mueallath, Al Harbi, Abdulmohsen Hamdan   +6 more
openaire   +1 more source

Gut microbiota alterations in patients with non‐small‐cell lung cancer undergoing chemoradiotherapy

Molecular Oncology, EarlyView.
We investigated the impact of concurrent chemoradiotherapy (CRT) on the gut microbiota in patients with locally advanced non‐small‐cell lung cancer. Overall gut microbiota composition remained largely stable throughout CRT while antibiotic exposure may influence microbial diversity.
Hanne Marte Nymoen, Zhi Zhao, Henrik Horndalsveen, Maria Moksnes Bjaanæs, Bjørn Henning Grønberg, Tarje Halvorsen, Tesfaye Madebo, Marianne Aanerud, Jussi Koivunen, Kersti Oselin, Saulius Cicenas, Nina Helbekkmo, Jarkko Ahvonen, Maria Silvoniemi, Tine Norman Alver, Tonje Dalen, Åsa Kristina Öjlert, Saima Jamil Farooqi, Åslaug Helland, Vilde Drageset Haakensen   +19 more
wiley   +1 more source

Effects of Add‐On Icosapent Ethyl With Standard Treatment on Functional Outcomes and Inflammatory Biomarkers in Acute Ischemic Stroke: A Blinded Randomized Controlled Trial

Annals of Clinical and Translational Neurology, EarlyView.
ABSTRACT Background Ischemic stroke, a major cause of mortality and long‐term disability, results from the abrupt cessation of cerebral blood flow due to vascular occlusion or rupture. Icosapent Ethyl (EPA‐EE), approved for hypertriglyceridemia, has anti‐inflammatory and antithrombotic properties that may lessen ischemic damage.
Mitra Mahmoudi Meymand, Seyed Hossein Aghamiri, Saeed Mohmammad Soleymani, Shadiyeh Bararpoor Poshkohi, Samaneh Masoudi, Hadi Esmaily   +5 more
wiley   +1 more source

Urine Drug Test Interpretation: An Educational Program's Impact on Resident Knowledge and Comfort Level

MedEdPORTAL, 2018
Introduction Following the release of the Centers for Disease Control and Prevention guidelines in 2016, institutions are encouraged to have controlled substance agreements that require the use of drug screens for appropriate opioid prescribing.
Whitney Aultman, Janna Fett, Colleen Lauster, Sarah Muench, Alexandra Halalau   +4 more
doaj   +1 more source

Vascular Disease, Non‐Steroidal Anti‐Inflammatory Drugs and Risk of Parkinson's Disease

Annals of Clinical and Translational Neurology, EarlyView.
ABSTRACT Objectives A history of vascular disease has been shown to be associated with an increased risk of Parkinson's disease, but this may be due to reverse causation. In addition, non‐steroidal anti‐inflammatory drugs are thought to reduce Parkinson's disease risk, but evidence is inconsistent and confounding by prior vascular disease is possible ...
Clare Wotton, Carol Hermon, Sarah Floud, Gillian Reeves, Isobel Barnes   +4 more
wiley   +1 more source